Search Results - "Dunavin, N"

Improved reproducibility and quality of GvHD biomarker assay: application of multiplex microfluidic channel system by Anandi, P, Tian, X, Chinian, F, Cantilena, C R, Dunavin, N, Hensel, N, Draper, D, Koklanaris, E, Maxwell, S, Superata, J, Muranski, P, Battiwalla, M, Paczesny, S, Barrett, A J, Ito, S

Get full text

Clinical comorbidity predictive measures in ex vivo T-cell-depleted allogeneic hematopoietic stem cell transplantation by Le, R Q, Tian, X, Jain, N A, Lu, K, Ito, S, Draper, D A, Anandi, P, Hourigan, C S, Dunavin, N, John Barrett, A, Battiwalla, M

Get full text

A phase i study to evaluate the safety of wharton's jelly mesenchymal stem cells for the treatment of de novo high risk or steroid refractory acute Graft Versus Host Disease (aGVHD) by Soder, R.P., Abhyankar, S., Morrison, M., Weir, S., Mitchell, J., Dunavin, N., Li, M., Shune, L., Singh, A., Ganguly, S., Dawn, B., McGuirk, J.

“…Allogeneic hematopoietic stem cell transplantation used to manage hematologic malignancies, is frequently complicated by graft versus host disease (GvHD)…”
Get full text

Outcomes of Vdpace with Immunomodulator Treatment in Initial and Relapsed/Refractory Multiple Myeloma in a Single Center by Abdallah, Al-Ola, McGuirk, Joseph P., Shune, Leyla, Hochard, Erica, Dunavin, Neil, Mahmoudjafari, Zahra, Ganguly, Siddhartha

“…Background: High- risk multiple myeloma (MM) is considered challenging to treat because of the risk of early relapse and increased mortality. The main factors…”
Get full text

PS1056 ACUTE MYELOID LEUKEMIA OR MYELODYSPLASTIC SYNDROME WITH CHROMOSOME 17 ABNORMALITIES AND LONG‐TERM OUTCOMES WITH OR WITHOUT HEMATOPOIETIC STEM CELL TRANSPLANTATION by Mohyuddin, G.R., Britt, A., Skikne, B., Singh, A., Lin, T., McGuirk, J., McClune, B., Ganguly, S., Abhyankar, S., Shune, L., Dunavin, N., Dias, A.

“…Background: Chromosome 17 (ch17) abnormalities, especially loss of the 17p region and P53 gene mutations (p53mut) result in very low rates of cure for patients…”
Get full text

D22 QUALITY IMPROVEMENT: ADMISSION TO DISCHARGE: Targeted Early Hospital Discharges (ted) A Novel Process Improvement Program At A Large Tertiary Care Teaching Hospital by Mastronarde, J G, Risaliti, C M, Allred, C, Rossetti, A, Gonsenhauser, I, Park, J, Velez, M, Hanks, C, Dunavin, N, Wininger, D, Nash, L, Tarver, V, Van Buren, A, Mansfield, J, Bruce, S Moffatt

Get full text

Reduced dose pentostatin for initial management of hairy cell leukemia patients who have active infection or risk of hemorrhage is safe and effective by Andritsos, Leslie A, Dunavin, Neil, Lozanski, Gerard, Jones, Jeffrey A, Blachly, James S, Lucas, David M, Byrd, John C, Kraut, Eric, Grever, Michael R

Get full text